Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease | PLOS ONE
Adalimumab drug monitoring
1 Scottish Biologic Therapeutic Drug Monitoring Service –Gastroenterology Guidance The purpose of this document is to provide
Optimizing Management with Anti-TNF Levels and Antibodies
A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis | Scientific Reports
TNFα Therapeutic Drug Monitoring - Calprotectin
Comparative Study of Both Versions of an Immunoassay Commercialized for Therapeutic Drug Monitoring of Adalimumab in Rheumatoid Arthritis | Reumatología Clínica
Optimizing Management with Anti-TNF Levels and Antibodies
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease | PLOS ONE
Frontiers | Clinical Evaluation of Humira® Biosimilar ONS-3010 in Healthy Volunteers: Focus on Pharmacokinetics and Pharmacodynamics
Monitoring your medication | Crohn's & colitis
Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay | Science Translational Medicine
Adalimumab | BIDMC
Algorithm for use of reactive therapeutic drug monitoring in IBD... | Download Scientific Diagram
Available now: The complete package for Therapeutic Drug Monitoring
Therapeutic Drug Monitoring - Gastrointestinal Society
Adalimumab Level with Reflex to Adalimumab Antibody
Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study - The Lancet Rheumatology
The 'Nuts and Bolts' of Drug Concentration Monitoring in IBD | GI and Hepatology News
Infliximab
Adalimumab Total Anti-drug ELISA (IDKmonitor®) | BIOHIT HealthCare Ltd
Frontiers | The First WHO International Standard for Adalimumab: Dual Role in Bioactivity and Therapeutic Drug Monitoring
Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay - ScienceDirect
Immunopharmacologic Monitoring of Therapeutic Serum Antibodies I. Policy Description II. Related Policies III. Indications and/o
Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives - Gastroenterology
